Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a minor website software/version update to how the history page is presented.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check17 days agoChange DetectedDifference0.1%

- Check38 days agoChange Detected- Revision notes updated: v3.5.0 added and v3.4.3 removed from the record history.SummaryDifference0.1%

- Check74 days agoChange DetectedNew revision entry v3.4.2 is added to the history and the previous revision v3.4.1 is removed, a minor bookkeeping update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page history shows a new site revision entry v3.4.1 and removal of v3.4.0; no study data or content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.